Cannabidiol for the treatment of psychosis in Parkinson’s disease
Identifieur interne : 002036 ( Main/Exploration ); précédent : 002035; suivant : 002037Cannabidiol for the treatment of psychosis in Parkinson’s disease
Auteurs : Aw Zuardi [Brésil] ; Jas Crippa [Brésil] ; Jec Hallak [Brésil] ; Jp Pinto [Brésil] ; Mhn Chagas [Brésil] ; Ggr Rodrigues [Brésil] ; Sm Dursun [Canada] ; V. Tumas [Brésil]Source :
- Journal of Psychopharmacology [ 0269-8811 ] ; 2009-11.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The management of psychosis in Parkinson’s disease (PD) has been considered a great challenge for clinicians and there is a need for new pharmacological intervention. Previously an antipsychotic and neuroprotective effect of Cannabidiol (CBD) has been suggested. Therefore, the aim of the present study was to directly evaluate for the first time, the efficacy, tolerability and safety of CBD on PD patients with psychotic symptoms. This was an open-label pilot study. Six consecutive outpatients (four men and two women) with the diagnosis of PD and who had psychosis for at least 3 months were selected for the study. All patients received CBD in flexible dose (started with an oral dose of 150 mg/day) for 4 weeks, in addition to their usual therapy. The psychotic symptoms evaluated by the Brief Psychiatric Rating Scale and the Parkinson Psychosis Questionnaire showed a significant decrease under CBD treatment. CBD did not worsen the motor function and decreased the total scores of the Unified Parkinson’s Disease Rating Scale. No adverse effect was observed during the treatment. These preliminary data suggest that CBD may be effective, safe and well tolerated for the treatment of the psychosis in PD.
Url:
DOI: 10.1177/0269881108096519
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001578
- to stream Istex, to step Curation: 001578
- to stream Istex, to step Checkpoint: 000812
- to stream Main, to step Merge: 002189
- to stream PascalFrancis, to step Corpus: 000403
- to stream PascalFrancis, to step Corpus: 000485
- to stream PascalFrancis, to step Curation: 000874
- to stream PascalFrancis, to step Checkpoint: 000489
- to stream Main, to step Merge: 002293
- to stream Main, to step Curation: 002036
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cannabidiol for the treatment of psychosis in Parkinson’s disease</title><author wicri:is="90%"><name sortKey="Zuardi, Aw" sort="Zuardi, Aw" uniqKey="Zuardi A" first="Aw" last="Zuardi">Aw Zuardi</name></author><author wicri:is="90%"><name sortKey="Crippa, Jas" sort="Crippa, Jas" uniqKey="Crippa J" first="Jas" last="Crippa">Jas Crippa</name></author><author wicri:is="90%"><name sortKey="Hallak, Jec" sort="Hallak, Jec" uniqKey="Hallak J" first="Jec" last="Hallak">Jec Hallak</name></author><author wicri:is="90%"><name sortKey="Pinto, Jp" sort="Pinto, Jp" uniqKey="Pinto J" first="Jp" last="Pinto">Jp Pinto</name></author><author wicri:is="90%"><name sortKey="Chagas, Mhn" sort="Chagas, Mhn" uniqKey="Chagas M" first="Mhn" last="Chagas">Mhn Chagas</name></author><author wicri:is="90%"><name sortKey="Rodrigues, Ggr" sort="Rodrigues, Ggr" uniqKey="Rodrigues G" first="Ggr" last="Rodrigues">Ggr Rodrigues</name></author><author wicri:is="90%"><name sortKey="Dursun, Sm" sort="Dursun, Sm" uniqKey="Dursun S" first="Sm" last="Dursun">Sm Dursun</name></author><author wicri:is="90%"><name sortKey="Tumas, V" sort="Tumas, V" uniqKey="Tumas V" first="V." last="Tumas">V. Tumas</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:615C88BFC3C2254F3F153F6F221162ADAFF93765</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1177/0269881108096519</idno><idno type="url">https://api-v5.istex.fr/document/615C88BFC3C2254F3F153F6F221162ADAFF93765/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001578</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001578</idno><idno type="wicri:Area/Istex/Curation">001578</idno><idno type="wicri:Area/Istex/Checkpoint">000812</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000812</idno><idno type="wicri:doubleKey">0269-8811:2009:Zuardi A:cannabidiol:for:the</idno><idno type="wicri:Area/Main/Merge">002189</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:10-0407259</idno><idno type="wicri:Area/PascalFrancis/Corpus">000403</idno><idno type="wicri:Area/PascalFrancis/Corpus">000485</idno><idno type="wicri:Area/PascalFrancis/Curation">000874</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000489</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000489</idno><idno type="wicri:doubleKey">0269-8811:2009:Zuardi A:cannabidiol:for:the</idno><idno type="wicri:Area/Main/Merge">002293</idno><idno type="wicri:Area/Main/Curation">002036</idno><idno type="wicri:Area/Main/Exploration">002036</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cannabidiol for the treatment of psychosis in Parkinson’s disease</title><author wicri:is="90%"><name sortKey="Zuardi, Aw" sort="Zuardi, Aw" uniqKey="Zuardi A" first="Aw" last="Zuardi">Aw Zuardi</name><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Brésil</country></affiliation></author><author wicri:is="90%"><name sortKey="Crippa, Jas" sort="Crippa, Jas" uniqKey="Crippa J" first="Jas" last="Crippa">Jas Crippa</name><affiliation wicri:level="4"><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Neuropsychiatry and Medical Psychology, Ribeirão Preto Medical School, University of São Paulo, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region><settlement type="city">São Paulo</settlement></placeName><orgName type="university">Université de São Paulo</orgName></affiliation></author><author wicri:is="90%"><name sortKey="Hallak, Jec" sort="Hallak, Jec" uniqKey="Hallak J" first="Jec" last="Hallak">Jec Hallak</name><affiliation wicri:level="4"><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Neuropsychiatry and Medical Psychology, Ribeirão Preto Medical School, University of São Paulo, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region><settlement type="city">São Paulo</settlement></placeName><orgName type="university">Université de São Paulo</orgName></affiliation></author><author wicri:is="90%"><name sortKey="Pinto, Jp" sort="Pinto, Jp" uniqKey="Pinto J" first="Jp" last="Pinto">Jp Pinto</name><affiliation wicri:level="4"><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Neuropsychiatry and Medical Psychology, Ribeirão Preto Medical School, University of São Paulo, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region><settlement type="city">São Paulo</settlement></placeName><orgName type="university">Université de São Paulo</orgName></affiliation></author><author wicri:is="90%"><name sortKey="Chagas, Mhn" sort="Chagas, Mhn" uniqKey="Chagas M" first="Mhn" last="Chagas">Mhn Chagas</name><affiliation wicri:level="4"><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Neuropsychiatry and Medical Psychology, Ribeirão Preto Medical School, University of São Paulo, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region><settlement type="city">São Paulo</settlement></placeName><orgName type="university">Université de São Paulo</orgName></affiliation></author><author wicri:is="90%"><name sortKey="Rodrigues, Ggr" sort="Rodrigues, Ggr" uniqKey="Rodrigues G" first="Ggr" last="Rodrigues">Ggr Rodrigues</name><affiliation wicri:level="4"><country xml:lang="fr">Brésil</country><wicri:regionArea>4 Department of Neuropsychiatry and Medical Psychology, Ribeirão Preto Medical School, University of São Paulo, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region><settlement type="city">São Paulo</settlement></placeName><orgName type="university">Université de São Paulo</orgName></affiliation></author><author wicri:is="90%"><name sortKey="Dursun, Sm" sort="Dursun, Sm" uniqKey="Dursun S" first="Sm" last="Dursun">Sm Dursun</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Psychiatry, University of Alberta, Edmonton, Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author><author wicri:is="90%"><name sortKey="Tumas, V" sort="Tumas, V" uniqKey="Tumas V" first="V." last="Tumas">V. Tumas</name><affiliation wicri:level="4"><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Neuropsychiatry and Medical Psychology, Ribeirão Preto Medical School, University of São Paulo, São Paulo</wicri:regionArea><placeName><settlement type="city">São Paulo</settlement><region type="state">État de São Paulo</region><settlement type="city">São Paulo</settlement></placeName><orgName type="university">Université de São Paulo</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Psychopharmacology</title><idno type="ISSN">0269-8811</idno><idno type="eISSN">1461-7285</idno><imprint><publisher>SAGE Publications</publisher><pubPlace>Sage UK: London, England</pubPlace><date type="published" when="2009-11">2009-11</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="979">979</biblScope><biblScope unit="page" to="983">983</biblScope></imprint><idno type="ISSN">0269-8811</idno></series><idno type="istex">615C88BFC3C2254F3F153F6F221162ADAFF93765</idno><idno type="DOI">10.1177/0269881108096519</idno><idno type="ArticleID">10.1177_0269881108096519</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0269-8811</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson disease</term><term>Psychosis</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term><term>Psychose</term><term>Traitement</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The management of psychosis in Parkinson’s disease (PD) has been considered a great challenge for clinicians and there is a need for new pharmacological intervention. Previously an antipsychotic and neuroprotective effect of Cannabidiol (CBD) has been suggested. Therefore, the aim of the present study was to directly evaluate for the first time, the efficacy, tolerability and safety of CBD on PD patients with psychotic symptoms. This was an open-label pilot study. Six consecutive outpatients (four men and two women) with the diagnosis of PD and who had psychosis for at least 3 months were selected for the study. All patients received CBD in flexible dose (started with an oral dose of 150 mg/day) for 4 weeks, in addition to their usual therapy. The psychotic symptoms evaluated by the Brief Psychiatric Rating Scale and the Parkinson Psychosis Questionnaire showed a significant decrease under CBD treatment. CBD did not worsen the motor function and decreased the total scores of the Unified Parkinson’s Disease Rating Scale. No adverse effect was observed during the treatment. These preliminary data suggest that CBD may be effective, safe and well tolerated for the treatment of the psychosis in PD.</div></front></TEI><affiliations><list><country><li>Brésil</li><li>Canada</li></country><region><li>État de São Paulo</li></region><settlement><li>São Paulo</li></settlement><orgName><li>Université de São Paulo</li></orgName></list><tree><country name="Brésil"><noRegion><name sortKey="Zuardi, Aw" sort="Zuardi, Aw" uniqKey="Zuardi A" first="Aw" last="Zuardi">Aw Zuardi</name></noRegion><name sortKey="Chagas, Mhn" sort="Chagas, Mhn" uniqKey="Chagas M" first="Mhn" last="Chagas">Mhn Chagas</name><name sortKey="Crippa, Jas" sort="Crippa, Jas" uniqKey="Crippa J" first="Jas" last="Crippa">Jas Crippa</name><name sortKey="Hallak, Jec" sort="Hallak, Jec" uniqKey="Hallak J" first="Jec" last="Hallak">Jec Hallak</name><name sortKey="Pinto, Jp" sort="Pinto, Jp" uniqKey="Pinto J" first="Jp" last="Pinto">Jp Pinto</name><name sortKey="Rodrigues, Ggr" sort="Rodrigues, Ggr" uniqKey="Rodrigues G" first="Ggr" last="Rodrigues">Ggr Rodrigues</name><name sortKey="Tumas, V" sort="Tumas, V" uniqKey="Tumas V" first="V." last="Tumas">V. Tumas</name></country><country name="Canada"><noRegion><name sortKey="Dursun, Sm" sort="Dursun, Sm" uniqKey="Dursun S" first="Sm" last="Dursun">Sm Dursun</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002036 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002036 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:615C88BFC3C2254F3F153F6F221162ADAFF93765
|texte= Cannabidiol for the treatment of psychosis in Parkinson’s disease
}}
| This area was generated with Dilib version V0.6.29. |  |